News

Shorcan Charity Day Raises $5,000 for Vision Research

Shorcan Charity Day Raises $5,000 for Vision Research

January 19th, 2018 by FFB Canada

Yesterday, we helped TMX Group close the market for the 20th Shorcan Charity Day! For the last 20 years, Shorcan Brokers Limited has donated one day’s profits to charities, including the Foundation Fighting Blindness (FFB). Today, we’re thrilled to announce that the FFB and the crucial vision research we support will benefit from $5,000 thanks to…

Read More

Racing Against the Clock

Racing Against the Clock

January 18th, 2018 by FFB Canada

Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and sight. They’ve both had hearing problems from day one, but cochlear implants have helped with that. They also have difficulties with balance, but…

Read More

2018 National Young Leaders Summit: Register Now!

2018 National Young Leaders Summit: Register Now!

December 28th, 2017 by Dr. Chad Andrews

The Foundation Fighting Blindness is thrilled to announce details for next year’s National Young Leaders Summit. The event will take place in Toronto on the evening of Friday, March 9 and during the day on Saturday, March 10, 2018. We are partnering with the Canadian National Institute for the Blind to hold the Summit at their Community Hub at…

Read More

2017 in Review: The Most-Read FFB Stories of 2017

2017 in Review: The Most-Read FFB Stories of 2017

December 22nd, 2017 by FFB Canada

At the FFB, we love writing about vision research. In 2017, we wrote more than 50 stories to share news about stem cell discoveries, CRISPR gene-editing, promising new drug therapies, and emerging treatments for blinding eye disease. Have you read them all? The best place to start is with our top 10 most-read stories of…

Read More

First gene therapy for a blinding eye disease receives FDA approval

First gene therapy for a blinding eye disease receives FDA approval

December 19th, 2017 by Dr. Mary Sunderland

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the US that targets a disease caused by mutations in a specific gene. The next steps involve determining the price for Luxturna, which poses…

Read More

Survival of the Fittest: Sustaining Cells Through Transplantation

Survival of the Fittest: Sustaining Cells Through Transplantation

December 18th, 2017 by Dr. Chad Andrews

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia, and Stargardt disease. To reverse vision loss resulting from these and similar diseases, we need to develop and refine our ability to replace…

Read More

Understanding the Retina: AMD and Exploratory Science

Understanding the Retina: AMD and Exploratory Science

December 1st, 2017 by Dr. Chad Andrews

In medicine, innovative treatments don’t emerge out of thin air; they are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye is no stranger to this rule. In fact, there is still much we don’t understand about the genetic and cellular foundations of sight….

Read More

Give the Gift of Sight

Give the Gift of Sight

November 27th, 2017 by FFB Canada

When my son Bennett was born, he was a beautiful, healthy baby boy. My husband and I couldn’t have been happier. But 10 weeks later, we got shocking news that knocked us off our feet – our little boy had a rare eye disease called juvenile retinoschisis and there was no cure. What we learned…

Read More

The Value of iPSCs for Stem Cell Therapy

The Value of iPSCs for Stem Cell Therapy

November 22nd, 2017 by Dr. Chad Andrews

Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field forward. By developing new techniques to turn induced pluripotent stem cells (iPSCs) into sheets of cone photoreceptors, Dr. Bernier and his team are…

Read More

Top 10 Things We Learned at Vision Quest 2017

Top 10 Things We Learned at Vision Quest 2017

November 7th, 2017 by Dr. Mary Sunderland

Vision Quest is the FFB’s educational program series that brings trusted information about emerging sight-saving treatments to people living with vision loss. This year, Vision Quest brought together more than 860 people at 9 different events across Canada. The entire FFB staff participates in Vision Quest because it gives us the opportunity to learn directly…

Read More